14 results match your criteria: "Reference Center for Inherited Platelet Disorders[Affiliation]"
BMJ Open
July 2025
Department of Cardiovascular Anesthesia and Critical Care, CHU Bordeaux, Haut-Lévêque hospital, Bordeaux, France.
Introduction: Cardiac surgery remains a high-risk procedure for bleeding despite advances in patient blood management. Conventional centrifugation-based autotransfusion devices primarily recover red blood cells, losing platelets and coagulation factors. The SAME autotransfusion device (i-SEP, Nantes, France) introduces an innovative filtration-based approach, recovering erythrocytes, leucocytes and platelets to enhance perioperative haemostasis.
View Article and Find Full Text PDFHaematologica
July 2025
Anne Bauters, Melanie Daniel, Camille Paris, Anabelle Dupont.
Germline variants of FLI1, essential for megakaryopoiesis, are linked to bleeding disorders, platelet aggregation defects and mild thrombocytopenia. However, the mechanisms behind these abnormalities remain unclear. This study aims to elucidate the impact of FLI1 variants on human megakaryocytes and platelets.
View Article and Find Full Text PDFHaemophilia
January 2025
Hematology Laboratory, Reference Center for Inherited Platelet Disorders, Aix-Marseille Univ, APHM, INSERM, INRAe, C2VN, Marseille, France.
Background: Platelet transfusion is considered the standard treatment for preventing or controlling severe haemorrhage in Glanzmann thrombasthenia (GT). However, platelet transfusion can have detrimental effects, including the production of anti-GPIIb/IIIa isoantibodies or anti-HLA antibodies (Ab) and platelet transfusion refractoriness. Recombinant activated factor VII (rFVIIa) has been proposed as an alternative treatment to platelet transfusion.
View Article and Find Full Text PDFRespir Med Res
November 2024
Hematology Department, European Hospital Georges-Pompidou, Paris, France; Paris Cité University, INSERM, Innovative Therapies in Haemostasis, Paris, France.
Pediatr Blood Cancer
February 2023
Adolescent and Young Adult Hematology Unit, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Int J Obstet Anesth
May 2022
Department of Anesthesiology, Armand Trousseau Children's Hospital, 75012 Paris, France. Electronic address:
Blood
April 2022
Reference Center for Hemophilia and Other Rare Inherited Bleeding Disorders, Bicêtre Hospital APHP, Le Kremlin-Bicêtre, France; and.
Glanzmann thrombasthenia (GT) is a rare inherited platelet function disorder caused by a quantitative and/or qualitative defect of the αIIbβ3 integrin. Pregnancy and delivery are recognized risk periods for bleeding in women with GT. The newborn may also be affected by fetal and neonatal immune thrombocytopenia induced by the transplacental passage of maternal anti-αIIbβ3 antibodies, which can lead to severe hemorrhage and fetal loss.
View Article and Find Full Text PDFHaematologica
February 2021
Inherited platelet disorders resulting from platelet function defects and a normal platelet count cause a moderate or severe bleeding diathesis. Since the description of Glanzmann thrombasthenia resulting from defects of ITGA2B and ITGB3, new inherited platelet disorders have been discovered, facilitated by the use of high throughput sequencing and genomic analyses. Defects of RASGRP2 and FERMT3 responsible for severe bleeding syndromes and integrin activation have illustrated the critical role of signaling molecules.
View Article and Find Full Text PDFPlatelets
May 2020
Department of Hematology, Besançon Hospital, Franche-Comté University, Besançon, France.
Gray platelet syndrome (GPS) is an inherited disorder. Patients harboring GPS have thrombocytopenia with large platelets lacking α-granules. A long-term complication is myelofibrosis with pancytopenia.
View Article and Find Full Text PDFHum Mutat
December 2019
Aix-Marseille Univ, INSERM, INRA, C2VN, Marseille, France.
The ACTN1 gene has been implicated in inherited macrothrombocytopenia. To decipher the spectrum of variants and phenotype of ACTN1-related thrombocytopenia, we sequenced the ACTN1 gene in 272 cases of unexplained chronic or familial thrombocytopenia. We identified 15 rare, monoallelic, nonsynonymous and likely pathogenic ACTN1 variants in 20 index cases from 20 unrelated families.
View Article and Find Full Text PDFBlood
December 2019
National Institute for Health Research (NIHR) BioResource, Cambridge University Hospitals, Cambridge Biomedical Campus, Cambridge, United Kingdom.
To identify novel causes of hereditary thrombocytopenia, we performed a genetic association analysis of whole-genome sequencing data from 13 037 individuals enrolled in the National Institute for Health Research (NIHR) BioResource, including 233 cases with isolated thrombocytopenia. We found an association between rare variants in the transcription factor-encoding gene IKZF5 and thrombocytopenia. We report 5 causal missense variants in or near IKZF5 zinc fingers, of which 2 occurred de novo and 3 co-segregated in 3 pedigrees.
View Article and Find Full Text PDFHaematologica
June 2018
APHM, La Timone Children's Hospital, Department of pediatric hematology and oncology, Marseille, France.
J Pediatr Hematol Oncol
November 2017
*Department of pediatric Hematology and Oncology #Haematological Laboratory **French Reference Center for Inherited Platelet Disorders, Trousseau Hospital (AP-HP) ∥Department of Immunology and Hematology, Necker Hospital (AP-HP) ¶Haematological Laboratory, Robert Debré Hospital (AP-HP) †UPMC U
Unlabelled: The most common cause of thrombocytopenia in children is immune thrombocytopenia. Nevertheless, some atypical cases should evoke the hypothesis of genetic thrombocytopenia. Indeed, in the past years, 30 new genes had been described in the field of inherited thrombocytopenia.
View Article and Find Full Text PDFHaematologica
August 2014
Department of Medicine and Haematology, University Hospital of Verona, Verona, Italy.
Pregnancy in women with inherited thrombocytopenias is a major matter of concern as both the mothers and the newborns are potentially at risk of bleeding. However, medical management of this condition cannot be based on evidence because of the lack of consistent information in the literature. To advance knowledge on this matter, we performed a multicentric, retrospective study evaluating 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia.
View Article and Find Full Text PDF